急诊科背景下肺动脉高压的评估与管理
该叙述性综述评估肺动脉高压,概述其复杂病理生理紊乱,并讨论急诊科对该患者群体的管理。美国约10-20%个体患有肺动脉高压,每年近12000例肺动脉高压患者因各种症状就诊急诊科。肺动脉高压分为5类,部分类别对特定治疗有反应。由于主诉常模糊非特异,急诊医师必须识别肺动脉高压表现及相关并发症以提供适当医疗。早期影像学检查如胸片、床旁超声心动图和计算机断层扫描有助于确定肺动脉高压加重的潜在病因。重启可能已停用的口服或静脉肺动脉高压药物在初始管理中至关重要。应极度注意避免缺氧和高碳酸血症,并维持右心室前负荷支持。除纠正潜在诱因外,审慎使用血管升压药和正性肌力药有助于纠正病理生理并避免进一步气道干预。理解肺动脉高压病理生理和可用急诊治疗可帮助急诊临床医师减少与该病相关的即时发病率和死亡率。
要点
- 美国约10-20%个体患有肺动脉高压,每年近12000例肺动脉高压患者就诊急诊科,主诉常模糊非特异。
- 肺动脉高压分为5类,部分类别对特定治疗有反应。
- 早期胸片、床旁超声心动图和计算机断层扫描有助于确定肺动脉高压加重的潜在病因。
- 重启可能已停用的口服或静脉肺动脉高压药物在初始管理中至关重要。
- 应极度注意避免缺氧和高碳酸血症,维持右心室前负荷支持,审慎使用血管升压药和正性肌力药。
适用人群与场景
- 急诊科就诊的肺动脉高压患者,表现为可能或可能不与肺动脉高压相关的各种症状。
处置流程与药物剂量
- 重启可能已停用的口服或静脉肺动脉高压药物。
- 避免缺氧和高碳酸血症。
- 维持右心室前负荷支持。
- 纠正潜在诱因。
- 审慎使用血管升压药和正性肌力药以纠正病理生理并避免进一步气道干预。
研究设计与关键结果
- 叙述性综述:评估肺动脉高压,概述复杂病理生理紊乱,并讨论急诊科管理。
证据类型、等级与局限
- 证据类型:叙述性综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 急诊医师应识别肺动脉高压表现及并发症以提供适当医疗。
- 早期影像学检查如胸片、床旁超声心动图和计算机断层扫描有助于确定肺动脉高压加重的潜在病因。
- 重启维持性肺动脉高压药物和正确选择血管升压药及正性肌力药将使失代偿的肺动脉高压患者获益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Pulmonary hypertension (PH) is characterized by increased pulmonary vascular resistance and pulmonary arterial pressure and is associated with significant morbidity and mortality.
OBJECTIVE: This narrative review evaluates PH, outlines the complex pathophysiologic derangements, and addresses the emergency department (ED) management of this patient population.
DISCUSSION: Approximately 10-20% of individuals in the United States suffer from PH. Each year nearly 12,000 PH patients seek care in the ED for a variety of symptoms which may or may not be related to PH. There are 5 classes of PH, some of which respond to particular therapies outlined in this review. As presenting complaints are frequently vague and non-specific, emergency physicians must recognize manifestations of PH and complications related to PH to deliver appropriate care. Early imaging with chest radiograph, bedside echocardiogram, and computed tomography can assist in determining the underlying etiology of PH exacerbation. Restarting oral or intravenous PH medications that may have been discontinued is crucial in initial management. Immense care should be taken to avoid hypoxia and hypercarbia as well as maintaining right ventricular preload support. In addition to correction of underlying precipitants, judicious vasopressor and inotrope use can help to correct pathophysiology and avoid further airway intervention.
CONCLUSIONS: An understanding of the pathophysiology of PH and available emergency treatments can assist emergency clinicians in reducing the immediate morbidity and mortality associated with this disease. Restarting maintenance PH medications and proper selection of vasopressors and inotropes will benefit decompensating patients with PH.
参考来源
- Simon E, Bridwell RE, Montrief T, et al. Evaluation and management of pulmonary hypertension in the emergency department setting. Am J Emerg Med. 2020. PMID: 32115291. doi:10.1016/j.ajem.2020.02.041
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。